Skip to main content

Published locations for RA: Tofacitinib modified-release 11 mg OD plus methotrexate shows promise in ORAL Shift trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. RA: Tofacitinib modified-release 11 mg OD plus methotrexate shows promise in ORAL Shift trial

User login

  • Reset your password
  • /content/ra-tofacitinib-modified-release-11-mg-od-plus-methotrexate-shows-promise-oral-shift-trial
  • /rheumatology/article/242068/rheumatoid-arthritis/ra-tofacitinib-modified-release-11-mg-od-plus